Intellectual Property Asia

AP reports that China has upheld the validity of Pfizer's patent on viagra and stopped two generic companies from selling products on the market. This follows the same court's decision in June overturning the revocation of the patent by the Patent Review Board. Good news for Pfizer - which has already lost its rights to the basic patent on Viagra in some countries due to a publication a few months prior to the filing of the patent rights.

AP report:

http://biz.yahoo.com/ap/061227/china_pfizer_viagra.html?.v=2

Labels: china, pfizer, viagra